Corporate governance and COVID-19: a literature review

DOIhttps://doi.org/10.1108/CG-10-2020-0447
Published date08 June 2021
Date08 June 2021
Pages969-982
Subject MatterStrategy,Corporate governance
AuthorAndreas Koutoupis,Panagiotis Kyriakogkonas,Michail Pazarskis,Leonidas Davidopoulos
Corporate governance and COVID-19: a
literature review
Andreas Koutoupis, Panagiotis Kyriakogkonas, Michail Pazarskis and
Leonidas Davidopoulos
Abstract
Purpose The purpose of this study is to review the literature on corporate governance (CG);
environmental,social and governance (ESG) issues andcorporate social responsibility (CSR) duringthe
Coronavirusdisease 2019 (COVID-19) pandemic and addresses threeresearch questions: What are the
characteristics of the literatureon CG and COVID-19? What are the themes in CG in the COVID-19 era?
and What are key areas of future researchon CG and COVID-19?
Design/methodology/approach The authors attempted a systematic literature review of 62 studies
published in 2020. The authors used four criteria to identify characteristics of the literature on CG and
COVID-19and three criteria to identify key themes in the literatureaddressing CG and the pandemic. The
authorsanalyzed answers to the above research questionsand proposals from studies reviewedto guide
futureresearch.
Findings CG in the contextof COVID-19 has been studied mostly in developedcountries and within a
theoretical framework. As accounting data are insufficient, more research is required in all countries
(developed, emerging and other). Further, there are no conclusive results regarding the relevance of
ESG and CSR to financialperformance. Future research should use additionalmethodologies and data
sourcesto fully explain the impact of COVID-19 on CG.
Practical implications Practitioners and policymakers could benefit from the study, as the authors
presentkey challenges to CG for the present andthe future.
Originality/value This study is the first to provide a systematic literature review on CG during the
COVID-19pandemic and presents current trends, challengesand avenues for future research.
Keywords CSR, Corporate governance, ESG, coronavirus disease 2019, pandemic
Paper type Literature review
1. Introduction
The Coronavirus disease 2019 (COVID-19) pandemic has arguably caused many
disturbances in every aspect of modern life. Firms and societies have had to cope with the
radical changes a global health pandemic imposes on its surroundings. Corporate
institutions have switched to safe mode and mechanisms that ensure the interests of
stakeholders have been put to the test. Environmental, social and governance (ESG) refers
to a set of standards to evaluate a firm’s performance regarding the protection of nature
(environment), its relationship with stakeholders, such as employees and suppliers (social)
and its governance as reflected in a firm’s management, executive remuneration and other
variables. Moreover, corporatesocial responsibility (CSR) and its positive impact on society
have become a priority alongside profit maximization. In this review, the authors have
broadly examined corporate governance (CG) and metrics of sustainability, such as ESG,
in the extraordinary context of the COVID-19 pandemic and provide early results.
Additionally, the systematic literature review highlights to market policymakers and
academics the key issues concerning CG and ESG and CSR and sustainability during the
first year of this health pandemic. Generally, the authors observe significant concern with
Andreas Koutoupis is
based at the Department of
Accounting and Finance,
University of Thessaly,
Volos, Greece.
Panagiotis Kyriakogkonas
is based at the School of
Economics, Business and
Computer Science,
Neapolis University
Paphos, Pafos, Cyprus.
Michail Pazarskis is based
at the Department of
Economics, International
Hellenic University, Thermi,
Greece.
Leonidas Davidopoulos is
based at the Department of
Accounting and Finance,
University of Thessaly,
Volos, Greece.
JEL classif‌ication G32, G34
Received 4 October 2020
Revised 28 January 2021
3 March 2021
21 March 2021
22 March 2021
Accepted 23 March 2021
DOI 10.1108/CG-10-2020-0447 VOL. 21 NO. 6 2021, pp. 969-982, ©Emerald Publishing Limited, ISSN 1472-0701 jCORPORATE GOVERNANCE jPAGE 969

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT